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276Objective: The aim of this study was to determine the feasibility and durability of truly stentless aortic valve
replacement using autologous pericardium sutured directly onto the aortic wall.
Methods: Eleven patients (mean age, 55.9 years) requiring aortic valve replacement were recruited. A circular
piece of pericardium about 8 cm in diameter was harvested and treated in 0.6% glutaraldehyde for 10 minutes.
The aortic valve was excised and, with the use of specially designed instruments (CardioMend LLC, Santa Bar-
bara, Calif), the sinotubular junction was sized and the pericardium was tailored to the required size and shape
and then sutured directly onto the aortic wall. The reconstructed valve was assessed directly and by echocardi-
ography at the end of the operation; it was assessed by echocardiography and cardiac magnetic resonance im-
aging at 6 months and yearly. Computed tomographic scan of the aortic valve to assess for valve calcification
was performed at last follow-up.
Results: Hospital mortality was 0%. Mean follow-up was 6.5 years (range, 5.37.5 years). Freedom from struc-
tural valve deterioration, thromboembolism, endocarditis and reoperationwas 100%, 100%, 72.7%, and 63.6%,
respectively. Therewere 4 reoperations at 4, 13, 15, and 46months, 3 of themowing to endocarditis and 1 owing to
technical failure noted at the time of surgery. The remaining 7 patients are alive and well with a mean New York
Heart Association class of 1.3 and normally functioning aortic valves with no calcification.
Conclusions: Truly stentless aortic valve replacement using autologous pericardium sutured directly onto the
aortic wall is safe and feasible and has excellent durability up to 7.5 years with no calcification. (J Thorac Car-
diovasc Surg 2011;141:276-83)Aortic valve replacement (AVR) with biological valves is in-
creasingly used in preference to mechanical valves owing to
the problems with anticoagulation. However, biological
valves are limited in their durability owing to valve degener-
ation and calcification.1-5 The precise mechanism of
calcification and pannus formation of bioprosthetic heart
valves is not fully known, but immune reaction between the
host and implanted valve and mechanical shear stress have
been implicated.5-8 The use of autologous pericardium for
AVR by direct suture of the autologous pericardium to the
aortic wall has several potential advantages. First, there is
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The Journal of Thoracic and Cardiovascular Surgvalve and so tissue calcification is reduced.1-3,9 Second,
direct suture of autologous pericardium onto the aortic
wall as valve leaflets to replace the aortic valve eliminates
the need for a valve stent, sewing ring, or cuff and so
preserves the normal dynamics of the aortic root, which
expands in systole and contracts in diastole.10-12 As
a result, mechanical shear stress on the valve leaflets is
reduced, an important cause of leaflet tears and
calcification in bioprosthetic valves.1-4,13 In addition, the
absence of a stent, sewing ring, or cuff in this truly
stentless aortic valve maximizes its effective orifice area.
These factors may lead to a valve substitute that has
optimal hemodynamics and improved durability.
We sought to determine in current contemporary practice
the feasibility and durability of truly stentless AVR using
autologous pericardium sutured directly onto the aortic
wall. We made use of novel specially designed instruments
by CardioMend LLC (Santa Barbara, Calif) to size and
shape the autologous pericardium. These instruments al-
lowed easy and reproducible sizing and shaping of the au-
tologous pericardium.14 To enable application of this
procedure in all types of aortic valves, including bicuspid
aortic valves, we sutured the autologous pericardium di-
rectly onto the aortic wall just above the aortic annulus,
and not to the aortic annulus itself. We also assessed valve
calcification at late follow-up by performing computedery c January 2011
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
CPB ¼ cardiopulmonary bypass
CT ¼ computed tomography
Chan et al Evolving Technology/Basic Sciencetomographic (CT) scans of the aortic valve. This is the first
report of autologous pericardial AVR using this technique
and with determination of late valve calcification.
PATIENTS AND METHODS
The studywas approved by the Brompton, Harefield, and National Heart
and Lung Institute Research Ethics Committee and was carried out at Hare-
field Hospital between February 2003 and May 2005. Eleven patients re-
quiring AVR were recruited after written informed consent had been
obtained. The mean age was 55.9 years (range, 22–75 years). There were
8 men and 3 women. The etiology of the aortic valve disease was aortic ste-
nosis in 8 patients (3 calcified bicuspid, 5 degenerative), and aortic insuf-
ficiency in 3 patients (2 endocarditis and 1 congenital quadricuspid
valve). Of the 2 patients with endocarditis, 1 had active endocarditis and
was operated on during the same hospital admission after receiving 2 weeks
of intravenous antibiotics. The other patient had healed endocarditis and
was operated on a year after his admission for endocarditis.
Surgical Technique
All operations were performed by the same surgeon (G.D.) at Harefield
Hospital. A circular piece of pericardium about 8 cm in diameter was har-
vested. It was cleared of any fibrous deposits and fatty tissue, then im-
mersed in 0.6% glutaraldehyde for 10 minutes, and then washed in 3
different normal saline washings for a further 10 minutes. During this
time, the patient was placed on cardiopulmonary bypass (CPB), an aorticFIGURE 1. Construction of the autologous pericardial aortic valve using Cardio
in size from 19 to 27 mm. B, The harvested autologous pericardium is placed o
tologous pericardium to cut it to the required size and shape. D, The cut pericard
a roller cutter. E, The trefoil of cut pericardium is shown after removal of the unw
be sutured to the aortic wall.
The Journal of Thoracic and Cacrossclamp applied, a transverse aortotomy performed, antegrade cold
blood cardioplegia delivered, the aortic valve excised, and the annulus
decalcified.
With the use of specially designed instruments (CardioMend), the sino-
tubular junction was sized, the pericardiumwas placed on a base, and a cut-
ting blade of the matching sizewas placed on top of the pericardium, which
cuts it to the required size and shape (a trefoil). The cut pericardium was
then mounted on a tissue holder to facilitate suturing it to the aortic wall
(Figure 1). The position of the commissures and base of the leaflet cusps
on the aortic root was determined using the specially designed instruments
and marked with methylene blue. In some cases, for example, in bicuspid
aortic valves, the position of the reconstructed commissures was indepen-
dent of the native commissures. The important principle was to ensure that
the newly reconstructed valvewas geometrically symmetrical and adequate
coaptation of the aortic valve leaflets was achieved.
The prepared autologous pericardiumwas then sutured directly onto the
aortic wall close to the marked annulus using 4–0 Prolene polypropylene
sutures (Ethicon, Inc, Somerville, NJ). The 2 commissural sutures for
each leaflet were placed first; thesewent through the aortic wall from inside
to outside and the knot was tied on the outside. A double-ended 4–0 Prolene
polypropylene suture was then placed at the base of the leaflet cusp; it was
stitched to the aortic wall just above the marked annulus and continued on
either side toward each commissure. Each running suture starting from the
base of the leaflet cusp ended at each commissure where it passed through
to the outside of the aorta, at which point the knot was tied (Figure 2). The
commissures were then securely fixed by passing another mattress suture
from inside the commissure to outside the aorta where it was tied. Leaflet
symmetry and coaptation were assessed directly at the end of the procedure
before closing the aortotomy and by transesophageal echocardiography on
coming off CPB.
Follow-up
All patients were followed up at the outpatient clinic of the operating
surgeon (G.D.) and with echocardiography and cardiac magnetic reso-
nance imaging at 6 weeks, 6 months, and yearly. At last follow-up, allMend instruments. A, The sinotubular junction is sized using sizers ranging
n a base. C, The cutter blade of the appropriate size is placed over the au-
ium before removal of the unwanted pieces. Any loose tissue is cut off with
anted pieces. F, The cut pericardium is placed on the tissue holder ready to
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FIGURE 2. Figures showing construction of the new aortic valve using
the preshaped autologous pericardium. A, The noncoronary cusp leaflet
has been sewn in using continuous 4–0 Prolene polypropylene sutures.
The commissural sutures are shown, which pass through the wall of the
aorta from inside to outside where the suture is tied. B, All 3 aortic leaflets
have been sutured in. The coaptation between the valve leaflets is shown
and the symmetry of the reconstructed valve leaflets is demonstrated.
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calcification.
Statistical Analysis
Data are presented as mean standard deviation. Comparison between
the baseline and last follow-up data was performed with a paired Student
t test using Stata version 10.0 (Stata Corporation, College Station, Tex).RESULTS
Hospital mortality was 0%. Concomitant procedures in-
cluded 1 ascending aortic replacement, 1 resection of sub-
valvular septal hypertrophy, 1 mitral valve annuloplasty,
and 1 coronary artery bypass graft operation. The mean
CPB and aortic crossclamp times were 162.4  30.6 min-
utes and 135.8  29.1 minutes, respectively. In patients
who did not have concomitant procedures, the mean CPB278 The Journal of Thoracic and Cardiovascular Surgand aortic crossclamp times were 140.8  14.4 minutes
and 114 9.5 minutes, respectively. These times compared
with mean CPB and aortic crossclamp times of 76.1  15.5
minutes and 57.6  16.6 minutes, respectively, in patients
having isolated conventional stented AVR.
The mean size of the aortic annulus was 26.1 mm (range,
23–27 mm). The aortic valve was successfully recon-
structed in all 11 patients and postoperative transesophageal
echocardiography showed excellent symmetry and coapta-
tion of the aortic valve leaflets with no aortic regurgitation
in 10 of the 11 patients. In the remaining patient, some pro-
lapse of the right coronary cusp was noted and there was
mild aortic regurgitation. All patients made an uneventful
postoperative recovery. The mean length of hospital stay
was 8.9  3.2 days.
There were 4 reoperations: 3 owing to endocarditis at 4,
13, and 46 months, and 1 at 15 months in the patient who
was noted to have some prolapse of the right coronary
cusp at the time of the initial operation. Of the 3 in
whom endocarditis developed, 2 had endocarditis at their
initial operation and the third had endocarditis develop af-
ter a dental procedure. The first patient, who was reoperated
on at 4 months, had active Staphylococcus aureus endocar-
ditis at his first operation, at which an abscess cavity was
present with perforation of the right coronary cusp. He re-
turned with recurrent endocarditis and a tear in the right
coronary cusp causing severe aortic regurgitation and un-
derwent valve replacement with a mechanical aortic valve.
The second patient, who was reoperated on at 13 months,
had Staphylococcus aureus endocarditis 1 year before his
original operation. He returned at 13 months with recurrent
Staphylococcus endocarditis causing an abscess in the non-
coronary sinus and severe aortic regurgitation and under-
went a homograft root replacement. The third patient,
who was reoperated on at 46 months, had Streptococcus mi-
tis endocarditis develop after a dental procedure, causing
a tear in the right coronary cusp and severe aortic regurgi-
tation, and underwent valve replacement with a mechanical
aortic valve. Histologic examination of these 3 explanted
valves confirmed features of endocarditis with no calcifica-
tion of the tissue. The fourth patient, who was reoperated on
at 15 months, had a technical failure at his original opera-
tion. The annulus was asymmetrical with the commissure
between the right and noncoronary cusps significantly dis-
placed. This was plicated with 5 Ethibond sutures (Ethicon)
reducing the size of the annulus. After construction of the
autologous pericardial aortic valve, some prolapse of the
right coronary cusp was noted. Transesophageal echocardi-
ography at the end of the procedure showed only mild aor-
tic insufficiency, but this subsequently progressed and
necessitated reoperation. Histologic examination of this ex-
planted valve showed preservation of the normal collagen
structure of the autologous pericardium with no calcifica-
tion (Figure 3).ery c January 2011
FIGURE 3. Histologic examination of the autologous pericardial valve explanted at 15 months owing to a technical failure showing preservation of the
normal collagen structure of the autologous pericardium with no calcification.
Chan et al Evolving Technology/Basic ScienceThe remaining 7 patients are all alive and well. Follow-up
was 100% completewith amean duration of 6.5 years (range,
5.37.5 years). Mean New York Heart Association class was
1.3, and all had normally functioning aortic valves with
a mean peak gradient of 10.9 mm Hg, mean peak velocity
of 1.4 m/s, and mean aortic insufficiency grade of 0.3
(Table 1). No patient had greater than mild aortic regurgita-
tion or stenosis. The normal function of the reconstructed aor-
tic valve was confirmed by cardiac magnetic resonance
imaging in all patients (Figure 4). Five patients consented to
a CT scan of the aortic valve at a mean of 6.5 years after sur-
gery (range, 6.0–7.2 years). In all 5 patients, therewas no cal-
cification of the aortic valve. Freedom from structural valve
deterioration, thromboembolism, endocarditis, and reopera-
tion was 100%, 100%, 72.7%, and 63.6%, respectively.DISCUSSION
This prospective pilot study of 11 patients has demon-
strated that replacement of the aortic valve with autologous
pericardium sutured directly onto the aortic wall is safe and
feasible. The hemodynamic performance of the valve is ex-
cellent with a minimal gradient across it and no aortic regur-
gitation. The absence of a supporting stent and sewing ring
in this truly stentless aortic valve maximizes its effective or-
ifice area and may make it particularly useful in those with
small aortic roots or poor left ventricular function, althoughTABLE 1. Comparison of baseline and last follow-up clinical and
echocardiographic data
Parameters Baseline Follow-up Change P*
NYHA class 2.4 (0.5) 1.3 (0.8) 1.1 .0047
LVESD (mm) 26.7 (2.9) 26.6 (4.0) 0.1 .94
LVEDD (mm) 44.1 (2.0) 43.9 (2.9) 0.2 .82
Peak aortic valve
gradient (mm Hg)
10.9 (10.5)
Peak aortic valve
velocity (m/s)
1.4 (0.8)
Mean aortic regurgitation
grade (0–4)
0.3 (0.5)
Left ventricular mass (g) 234 (52.1) 195.1 (41.1) 38.9 .068
NYHA, New York Heart Association; LVESD, left ventricular end-systolic dimen-
sion; LVEDD, left ventricular end-diastolic dimension. *Student paired t test.
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time required for this procedure.15 It has excellent durabil-
ity up to 7.5 years with a freedom from structural valve de-
terioration of 100%, which is comparable with, if not better
than, conventional bioprosthetic aortic valves given the
younger age group of patients in this study.1,2,16 This is
consistent with a previous study that reported a freedom
from structural valve deterioration of 80% at 10 years in
young patients who had autologous pericardial AVR.17
The autologous pericardial aortic valve is nonthrombogenic
with no need for anticoagulation as demonstrated in this and
previous studies.17
The use of autologous pericardium avoids any immune
reaction between the host and the implanted heart valve
and so minimizes tissue calcification and pannus formation,
which are important causes of structural valve deterioration
in bioprosthetic heart valves.1,3,5,8 This was confirmed in
the present study by the absence of any valve calcification
when assessed by CT scan at a mean of 6.5 years and also
by the absence of any calcification in the 4 explanted
autologous pericardial valves.3,9,17,18
Previous attempts at using untreated autologous tissue
for AVR had been troubled by shrinkage and retraction of
the tissue.19 This problem appears to have been alleviated
by pretreatment of the autologous tissue with 0.6% glutaral-
dehyde, which preserves the structure of the autologous tis-
sue, a concept first described in 1986.20 A recent study
demonstrated freedom from structural valve deterioration of
80% at 10yearswith autologous pericardial aortic valves pre-
treated with glutaraldehyde and no calcification or tissue re-
traction in those who had reoperations.17 Studies of aortic
valve repair with leaflet augmentation using autologous
pericardium pretreated with glutaraldehyde have also consis-
tently reported excellent durability of the autologous pericar-
dial patch, with 1 study reporting no structural dysfunction of
the autologous pericardial leaflet extension at 13 years, and in
patients needing reoperation, no calcification was found.21
Similarly, glutaraldehyde-treated autologous pericardial
patches used for leaflet extension in mitral valve repair have
shown excellent durability with no calcification.22
The direct suture of autologous pericardium to the aortic
wall creating a new aortic valve avoids the need for anyrdiovascular Surgery c Volume 141, Number 1 279
FIGURE 4. Series of cardiac magnetic resonance images demonstrating the normal function and geometry of the reconstructed autologous pericardial
aortic valve in a patient 6 years after the operation. A and B, Left ventricular outflow tract and ascending aortic views in diastole demonstrating normal
coaptation between the valve leaflets and no regurgitation. C, Transverse aortic valve view in diastole demonstrating coaptation between the valve leaflets
and its symmetrical trileaflet geometry. D, E, and F, Corresponding images in systole showing normal symmetrical opening of the reconstructed aortic valve
leaflets.
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Ssupporting stent, sewing ring, or cuff and so preserves the nor-
mal dynamics of the aortic root, which expands in systole and
contracts in diastole.10-12 This reduces the mechanical shear
stress on the reconstructed valve leaflet as it is allowed to
move with the aortic wall during the cardiac cycle and so
may improve its durability by reducing leaflet tears and also
calcification.3,13,18 Valve hemodynamics and effective
orifice area are also optimized. Studies on stentless aortic
valve bioprostheses have shown this to be advantageous,
particularly in patients with small aortic roots and impaired
left ventricular function.15 The benefits from this truly stent-
less valve may be even better than those of commercially
available stentless valves, which all have a sewing cuff and
thus do not fully allow for preservation of the normal dynam-
ics of the aortic root, although the reproducibility of this pro-
cedure among different surgeons may not be as good as in
commercially available stentless valves.
In a previous study of autologous pericardial AVR, the
autologous pericardium was sutured directly to the aortic
annulus, not the aortic wall.17 This has important limita-280 The Journal of Thoracic and Cardiovascular Surgtions inasmuch as it assumes that all 3 aortic sinuses are
symmetrical and would exclude bicuspid aortic valves
from the procedure. The sizing and shaping of the autolo-
gous pericardium also did not appear easily reproducible.
In the present study, the autologous pericardium was su-
tured directly to the aortic wall just above the aortic annulus
(and not to the aortic annulus itself), allowing us to recon-
struct 3 symmetrical aortic valve leaflets independent of
the geometry of the native aortic valve. Three of the surgi-
cally treated patients had bicuspid aortic valves and 1 had
a quadricuspid aortic valve. We made use of specially de-
signed instruments (CardioMend), which allowed for easy
and reproducible sizing and shaping of the autologous peri-
cardial aortic valve.14 Although a cost-comparison analysis
was not done, it is likely that this procedure will have a sig-
nificantly lower cost than that of conventional AVR using
a bioprosthesis.
It is accepted that the implantation of autologous pericar-
dial aortic valves by direct suture to the aortic wall is more
technically challenging than a conventional stented orery c January 2011
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asymmetry of the aortic annulus. It can be challenging to
determine the true height of the commissures, and some ex-
perience with aortic valve surgery is necessary. The impor-
tant principle is to create 3 symmetrical valve leaflets and
commissures and to ensure adequate coaptation between
them with no prolapse at the end of the procedure. Align-
ment of the 3 new commissures of the reconstructed valve
may need to be independent of that of the native valve if
asymmetry is present, and this is enabled by suturing the
new valve directly to the aortic wall just above the native
aortic annulus and not to the aortic annulus itself. In the
present study, technical failure resulted in the need for reop-
eration in 1 patient. It should be noted that the present study
reports the first 11 patients operated on by the same surgeon
(G.D.) using this new technique and so is part of the learn-
ing curve of the surgeon. It is likely that the results of sub-
sequent patients will be better once the learning curve has
been passed.
The high rate of endocarditis of 27.3% at 7.5 years is
a concern and appears much higher than that reported for
bioprosthetic aortic valves.1,2 A previous study using
autologous pericardium for AVR also reported a high rate
of endocarditis of 10.7% at 16 years.17 It is unknown
whether autologous tissue has an inherently higher risk of
endocarditis. It should be noted, however, that in the present
study, 2 of the 3 patients in whom endocarditis developed
had endocarditis as the indication for their original opera-
tion, and reinfection of prosthetic valves after valve replace-
ment for endocarditis is a recognized problem. The third
patient in whom endocarditis developed in the present study
had an invasive dental procedure. A further factor that
should be considered is that ultrafiltration of the glutaralde-
hyde to limit bacterial contamination was not done in this
study, and preparation of the chemical was not done in
the operating theater but in the pharmacy department, where
conditions of asepsis may not have been as vigilant. None-
theless, the results of the present study strongly suggest that
autologous tissue should not be used for valve replacement
in the presence of endocarditis, and appropriate antibiotic
prophylaxis needs to be taken for any invasive dental or sur-
gical procedure.
This truly stentless autologous pericardial aortic valve
with optimal hemodynamics and possibly improved dura-
bility may be particularly advantageous in younger active
patients who either cannot or do not want to take anticoagu-
lation. It is much less invasive and requires less distortion of
the aortic root geometry than does a Ross procedure or a ho-
mograft. Although it was previously believed that the pul-
monary autograft was the ideal valve substitute in these
patients, it is now emerging that its durability may be lim-
ited beyond the first decade, in addition to the previously
recognized limited durability of the homograft in the pul-
monary position.23 It is also a more technically challengingThe Journal of Thoracic and Caoperation to perform. Homografts in the aortic position, al-
though previously used in younger patients, have now been
shown to be less durable than commercially available stent-
less biological valves and so cannot be recommended as the
ideal valve substitute in these patients.24
A further advantage in this truly stentless autologous
pericardial aortic valve is that should reoperation be neces-
sary, it is technically a much easier operation to perform
than a reoperation for a failed homograft or bioprosthetic
valve; in fact, it is like a first-time AVR once access to the
aortic valve has been obtained. There is no calcification of
the valve leaflets or the aortic wall, as would be the case
if a homograft had been used, no need to explant a biopros-
thetic valve, and no need to reconstruct the aortic root, as
may be necessary if a stentless valve or homograft had
been implanted as a root replacement. Furthermore, should
transcatheter valve implantation be considered for these pa-
tients in future, there is no concern of patient–prosthesis
mismatch as may occur if a transcatheter valve is placed in-
side a stented or stentless bioprosthesis.CONCLUSIONS
Truly stentless AVR using autologous pericardium su-
tured directly onto the aortic wall without supporting stents
is safe and feasible and results in a valve with excellent he-
modynamics and preservation of the normal dynamics of
the aortic root. It has excellent durability up to 7.5 years
with no calcification. This valve may be particularly useful
for younger patients who cannot or do not want to take anti-
coagulation and for those with a small aortic root and poor
left ventricular function. Reoperation, if necessary, is tech-
nically unchallenging compared with other valve substi-
tutes. The overall experience with autologous pericardial
aortic valves is still limited and further studies involving
larger numbers of patients are needed, including random-
ized trials comparing autologous valves with conventional
bioprosthetic aortic valves.
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Dr Michael Acker (Philadelphia, Pa). I have a couple of
technical questions. Can this procedure be done in a bicuspid valve
that might not be symmetric where you have to really nail where
your commissures are, and what are the size limitations of this
technique?282 The Journal of Thoracic and Cardiovascular SurgDr Chan. Thank you for your question, Dr Acker. Yes, it can be
done. We have in fact done a few bicuspid valves and even a quad-
ricuspid valve. The important principle is to attain symmetry of the
leaflets and commissures at the end of the operation, and this is
done in some cases independent of the native commissures. We
place the sutures not actually on the annulus itself but slightly
above the annulus on the aortic wall.
The sizes provided by the company (CardioMend) that supplies
these instruments range from 19 mm to 27 mm, and we have done
operations in all these sizes.
Dr Nawwar Al–Attar (Paris, France). My question is practi-
cally a follow-up of the same question. You had described 1 of
your patients as having had a quadricuspid valve.Was this a patient
who had a technical failure? Would this procedure be contraindi-
cated for patients who do not have tricuspid valves, for your
kind of valve, for this technique?
Dr Chan. Thank you for your question. The patient who had
a quadricuspid valve is doing very well. The complication was
in a patient with a bicuspid valve who had a very gross asymmetry
of the annulus and commissures. It is certainly much easier to do
this operation in a tricuspid valve with symmetry of the annulus,
and it is certainly more challenging in bicuspid valves; in quadri-
cuspid valves it is certainly very challenging.
Dr Wolfgang Harringer (Braunschweig, Germany). What we
have learned from the trials with intraoperatively manufactured
stented valves is that the quality of the pericardium is not equal
in all the patients. In other words, it differs depending on the
area of the pericardium you are taking; it also differs, for example,
between a strong man and an old woman. Did you perform any
quality assessment? What guided your judgment to choosing ap-
propriate areas of the pericardium?
Dr Chan. Thank you for your question. No, there was no pre-
cise quality control. It was macroscopic on surgical view. The peri-
cardium had to be clean. We cleaned it of all fatty and fibrous
tissue, and it had to look good macroscopically. But we did not
do any further analysis on this pericardium. It was autologous
and harvested at the time of surgery.
Dr Boulos Asfour (Sankt Augustin, Germany). We have done
about 120 repairs in aortic valves in all kind of sizes, even in
infants. Many times when you look at the valve, you do not
want to throw away the whole valve and put in this kind of peri-
cardial valve. In the case of a valve affected by endocarditis
with 1 leaflet being severely damaged, would you consider cut-
ting out one of these cusps, replacing it, and leaving the others
alone?
Dr Chan. Thank you for your question. Yes, the option of aortic
valve repair is certainly open. In this series, none of the patients
would have been unsuitable for aortic valve repair; 8 of them
had calcified degenerative valve disease and the other 2 had severe
aortic regurgitation from endocarditis. We are a bit concerned
about using this for endocarditis now, given the high recurrence
of endocarditis in our series and also in Duran’s article. Thus we
would not recommend this technique in the presence of endocardi-
tis today.
Dr A. W. Atkinson (Raleigh, NC). This refers to the endocar-
ditis question. You mentioned an earlier article with a high inci-
dence of late endocarditis. It appears that this new biological
system, if you want to call it that, is not inert, or there is a chronicery c January 2011
Chan et al Evolving Technology/Basic Scienceinflammatory process that is the nidus for endocarditis. Can you
discuss that? Did you learn anything from the explantation of
the infected valve that you had?
Dr Chan. Thank you for your question. I do not think we know
the answer. In our series all 3 patients in whom endocarditis devel-The Journal of Thoracic and Caoped had risk factors to account for the endocarditis. Two of them
had Staphylococcus aureus endocarditis as the indication for the
original operation and a third had a dental procedure before endo-
carditis developed. However, I think the incidence of endocarditis
is certainly a concern.rdiovascular Surgery c Volume 141, Number 1 283
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